Cem Mirili

403 total citations
21 papers, 293 citations indexed

About

Cem Mirili is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cem Mirili has authored 21 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cem Mirili's work include Inflammatory Biomarkers in Disease Prognosis (10 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Cem Mirili is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (10 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Cem Mirili collaborates with scholars based in Türkiye. Cem Mirili's co-authors include Ali Yılmaz, Mehmet Bilici, Salim Başol Tekin, Semra Paydaş, Mustafa Yaprak, Gülşah Şeydaoğlu, Gülay Aşçı, Erhan Tatar, Melek Ergin and Emine Kılıç and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Colorectal Disease and Leukemia Research.

In The Last Decade

Cem Mirili

20 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cem Mirili Türkiye 9 212 80 45 35 35 21 293
Ali Yılmaz Türkiye 10 243 1.1× 77 1.0× 64 1.4× 63 1.8× 31 0.9× 25 347
Fahriye Tuğba Köş Türkiye 10 182 0.9× 77 1.0× 50 1.1× 28 0.8× 19 0.5× 40 274
L. Bigay-Gamé France 10 126 0.6× 193 2.4× 26 0.6× 43 1.2× 27 0.8× 32 343
Serkan Menekşe Türkiye 8 154 0.7× 75 0.9× 34 0.8× 31 0.9× 9 0.3× 26 203
Alberto Agazzi Italy 9 112 0.5× 70 0.9× 50 1.1× 44 1.3× 12 0.3× 19 396
Snehal G. Thakkar United States 9 141 0.7× 207 2.6× 39 0.9× 43 1.2× 34 1.0× 18 427
Luisa Ricaurte United States 11 97 0.5× 171 2.1× 70 1.6× 35 1.0× 15 0.4× 25 370
Qingyong Xu China 5 247 1.2× 72 0.9× 78 1.7× 59 1.7× 26 0.7× 6 336
Poompis Pattaranutaporn Thailand 10 133 0.6× 80 1.0× 115 2.6× 47 1.3× 42 1.2× 29 336

Countries citing papers authored by Cem Mirili

Since Specialization
Citations

This map shows the geographic impact of Cem Mirili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cem Mirili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cem Mirili more than expected).

Fields of papers citing papers by Cem Mirili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cem Mirili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cem Mirili. The network helps show where Cem Mirili may publish in the future.

Co-authorship network of co-authors of Cem Mirili

This figure shows the co-authorship network connecting the top 25 collaborators of Cem Mirili. A scholar is included among the top collaborators of Cem Mirili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cem Mirili. Cem Mirili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paydaş, Semra, et al.. (2022). Sarcoma – correlation between CD73 and PD-L1 and their relationship with prognosis. Polish Journal of Pathology. 73(4). 338–342. 1 indexed citations
2.
Paydaş, Semra, et al.. (2021). The effect of preferentially expressed antigen in melanoma (PRAME) expression status on survival in stage II and stage III colon cancer.. PubMed. 26(3). 992–1001. 1 indexed citations
3.
Mirili, Cem, et al.. (2020). The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen. Journal of Gastrointestinal Cancer. 52(1). 249–255. 5 indexed citations
4.
Mirili, Cem, et al.. (2020). Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases. Turkish Journal of Hematology. 37(4). 220–225. 4 indexed citations
5.
Mirili, Cem & Mehmet Bilici. (2020). Inflammatory prognostic markers in endometrial carcinoma: Systemic immune-inflammation index and prognostic nutritional index. Medical Science and Discovery. 7(1). 351–359. 8 indexed citations
6.
Mirili, Cem, Semra Paydaş, Emine Kılıç, et al.. (2020). Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer.. PubMed. 25(1). 159–167. 5 indexed citations
7.
Yılmaz, Ali, Cem Mirili, Mehmet Bilici, & Salim Başol Tekin. (2020). Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia. Journal of Oncology Pharmacy Practice. 26(7). 1791–1794. 12 indexed citations
8.
Yılmaz, Ali, Cem Mirili, Mehmet Bilici, & Salim Başol Tekin. (2019). Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations. International Journal of Colorectal Disease. 35(2). 351–353. 8 indexed citations
9.
Mirili, Cem, et al.. (2019). Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. International Journal of Clinical Oncology. 24(10). 1301–1310. 80 indexed citations
10.
11.
Yılmaz, Ali, Cem Mirili, Salim Başol Tekin, & Mehmet Bilici. (2019). The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study. Irish Journal of Medical Science (1971 -). 189(1). 91–102. 30 indexed citations
12.
Mirili, Cem. (2019). The ratio of hemoglobin-to-red cell distribution width could predict survival in advanced pancreatic adenocarcinoma. Leukemia Research. 85. S74–S74. 1 indexed citations
13.
Mirili, Cem, Ali Yılmaz, Mehmet Bilici, & Salim Başol Tekin. (2019). Long-Term Follow-Up Outcomes of Cervical Cancer Patients: A Single Center Experience from the East Anatolian Region of Turkey. SHILAP Revista de lepidopterología. 46(4). 857–865. 1 indexed citations
14.
Mirili, Cem, et al.. (2019). Systemic Immune-Inflammation Index Predicting Survival Outcome in Patients with Classical Hodgkin Lymphoma. Biomarkers in Medicine. 13(18). 1565–1575. 36 indexed citations
15.
Bişgin, Atıl, et al.. (2019). Results of liquid biopsy studies by next generation sequencing in patients with advanced stage non-small cell lung cancer: Single center experience from Turkey. SHILAP Revista de lepidopterología. 22(2). 17–24. 4 indexed citations
16.
Mirili, Cem, et al.. (2018). Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET–CT metabolic parameters in small cell lung cancer (SCLC). International Journal of Clinical Oncology. 24(2). 168–178. 32 indexed citations
17.
Mirili, Cem, et al.. (2018). Pulmonary MALT lymphoma with underlying interstitial lung disease: A case report and rewiev of the literature. SHILAP Revista de lepidopterología. 4(1). 56–59. 2 indexed citations
18.
19.
Paydaş, Semra, et al.. (2018). G-CSF related hemophagocytosıs in a case with lymhphoma. 4(1). 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Yılmaz Breakdown of academic impact, for papers by Fahriye Tuğba Köş Breakdown of academic impact, for papers by L. Bigay-Gamé Breakdown of academic impact, for papers by Serkan Menekşe Breakdown of academic impact, for papers by Alberto Agazzi Breakdown of academic impact, for papers by Snehal G. Thakkar Breakdown of academic impact, for papers by Luisa Ricaurte Breakdown of academic impact, for papers by Qingyong Xu Breakdown of academic impact, for papers by Poompis Pattaranutaporn
Rankless by CCL
2026